Literature DB >> 16050977

Cyclical mitochondrial deltapsiM fluctuations linked to electron transport, F0F1 ATP-synthase and mitochondrial Na+/Ca+2 exchange are reduced in Alzheimer's disease cybrids.

Christine Thiffault1, James P Bennett.   

Abstract

Reduced complex IV, increased oxidative stress and beta amyloid peptide secretion in Alzheimer's disease (AD) can be replicated in cybrid models. We characterized cyclical mitochondrial deltapsiM fluctuations ('flickering') in neuroblastoma cells and AD/CTL cybrids. Flickering was blocked by ATP-synthase inhibition, was not observed in rho0 cells and was not blocked by antioxidant treatment. Flickering was not affected by the Ca(+2) uniporter antagonist Ru360 but was eliminated by BAPTA or CGP37137 blockade of the mitochondrial Na(+)/Ca(+2) exchanger. AD cybrid mitochondria showed reduced flickering. Flickering seems to represent coupling of deltapsiM to F0F1 ATP-synthase; reduction of flickering in AD cybrids suggests dysfunction of this coupling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16050977     DOI: 10.1016/j.mito.2004.12.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  18 in total

1.  Linking flickering to waves and whole-cell oscillations in a mitochondrial network model.

Authors:  Melissa Nivala; Paavo Korge; Michael Nivala; James N Weiss; Zhilin Qu
Journal:  Biophys J       Date:  2011-11-01       Impact factor: 4.033

Review 2.  Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection.

Authors:  Gregor Zündorf; Georg Reiser
Journal:  Antioxid Redox Signal       Date:  2010-10-06       Impact factor: 8.401

Review 3.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease.

Authors:  Ilya Bezprozvanny; Mark P Mattson
Journal:  Trends Neurosci       Date:  2008-07-31       Impact factor: 13.837

Review 4.  Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.

Authors:  Md Farhad Hossain; Md Sahab Uddin; G M Sala Uddin; Dewan Md Sumsuzzman; Md Siddiqul Islam; George E Barreto; Bijo Mathew; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2019-06-17       Impact factor: 5.590

Review 5.  A mitochondrial etiology of Alzheimer and Parkinson disease.

Authors:  Pinar Coskun; Joanne Wyrembak; Samual E Schriner; Hsiao-Wen Chen; Christine Marciniack; Frank Laferla; Douglas C Wallace
Journal:  Biochim Biophys Acta       Date:  2011-08-16

6.  Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia.

Authors:  Pinar E Coskun; Joanne Wyrembak; Olga Derbereva; Goar Melkonian; Eric Doran; Ira T Lott; Elizabeth Head; Carl W Cotman; Douglas C Wallace
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

Review 8.  Mitochondria, Cybrids, Aging, and Alzheimer's Disease.

Authors:  R H Swerdlow; S Koppel; I Weidling; C Hayley; Y Ji; H M Wilkins
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-01       Impact factor: 3.622

9.  NLRP5 mediates mitochondrial function in mouse oocytes and embryos.

Authors:  Roxanne Fernandes; Chiharu Tsuda; Alagammal L Perumalsamy; Taline Naranian; Jasmine Chong; Beth M Acton; Zhi-Bin Tong; Lawrence M Nelson; Andrea Jurisicova
Journal:  Biol Reprod       Date:  2012-05-03       Impact factor: 4.285

10.  Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry.

Authors:  Laura González-Lafuente; Javier Egea; Rafael León; Francisco J Martínez-Sanz; Leticia Monjas; Concepción Perez; Cristina Merino; Antonio M García-De Diego; María I Rodríguez-Franco; Antonio G García; Mercedes Villarroya; Manuela G López; Cristóbal de Los Ríos
Journal:  ACS Chem Neurosci       Date:  2012-03-26       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.